InvestorsHub Logo
Followers 0
Posts 43
Boards Moderated 0
Alias Born 04/13/2022

Re: None

Monday, 04/10/2023 8:55:31 AM

Monday, April 10, 2023 8:55:31 AM

Post# of 28488
We should see the long awaited FY22 and Q4 22 UST related revenues by next Monday.

PRESSURE BIOSCIENCES, INC. (the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”) by the March 31, 2023 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant in completing its financial statements and other disclosures in the Annual Report. As a result, the Registrant is still in the process of compiling required information to complete the Annual Report and its independent registered public accounting firm requires additional time to complete its review of the financial statements for the period ended December 31, 2022 to be incorporated in the Annual Report. The Registrant anticipates that it will file the Annual Report no later than April 17, 2023 (the first business day after the fifteenth calendar day following the prescribed filing date
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PBIO News